Ignite Creation Date:
2025-12-24 @ 9:17 PM
Ignite Modification Date:
2026-05-03 @ 8:25 PM
Study NCT ID:
NCT06225804
Status:
RECRUITING
Last Update Posted:
2024-03-18
First Post:
2024-01-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer
Sponsor:
Abbisko Therapeutics Co, Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ABSK112-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None